hy wins approval from the US FDA for its probiotics
hy wins approval from the US FDA for its probiotics
  • Kim Min-jee
  • 승인 2021.12.16 13:52
  • 댓글 0
이 기사를 공유합니다

Headquarters of hy / Courtesy of hy

hy announced on December 16 that its probiotics "HY7601" and "HY7714" won by the US FDA as New Dietary Ingredient (NDI).

NDI is a system that is recognized as a new health food raw material by having proven the safety of raw materials by the FDA.

HY7601 is a raw material for “Kill Fat,” a material approved by the Ministry of Food and Drug Safety. Kill Fat is a functional probiotic that can help reduce body fat.

HY7714 is a skin lactobacillus derived from breast milk. It can help maintain skin health from skin moisture and UV damage.

Last month, hy also won FDA Generally Recognized as Safe (GRAS) for two types of lactic acid bacteria, Kill Fat and Skin Health, HY7714. This made it possible to sell all of hy's main B2B products overseas.

Proven raw material stability drives sales. Cumulative sales of Kill Fat and HY7714 this year are 5.2 tons and 2.2 tons, respectively.

Meanwhile, hy launched a B2B exclusive brand "hyLabs" in May and is supplying 5 types of probiotics to about 10 places including Chong Kun Dang Healthcare.
 


댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.

  • ABOUT
  • CONTACT US
  • SIGN UP MEMBERSHIP
  • RSS
  • 2-D 678, National Assembly-daero, 36-gil, Yeongdeungpo-gu, Seoul, Korea (Postal code: 07257)
  • URL: www.koreaittimes.com | Editorial Div: 82-2-578- 0434 / 82-10-2442-9446 | North America Dept: 070-7008-0005 | Email: info@koreaittimes.com
  • Publisher and Editor in Chief: Monica Younsoo Chung | Chief Editorial Writer: Hyoung Joong Kim | Editor: Yeon Jin Jung
  • Juvenile Protection Manager: Choul Woong Yeon
  • Masthead: Korea IT Times. Copyright(C) Korea IT Times, All rights reserved.
ND소프트